International PostDoc
- Research & Development
- Denmark - Måløv
The position is offered as part of the Novo Nordisk R&D STAR Programme (Science, Talent, Attraction and Recruitment). This programme supports the brightest graduate students in biotechnology, life, medical and engineering sciences, who want to pursue a career in pharmaceutical R&D.
About the department
Translational Haemophilia Pharmacology is offering an international Postdoc fellowship to a highly motivated and ambitious candidate. Translational Haemophilia Pharmacology is a research unit focusing on research and development of drug candidates for the treatment of haemophilia; we support the Novo Nordisk haemophilia portfolio with knowledge generated in animal models of haemophilia.
The Job
The project will first focus on optimizing and validating a thrombin generation assay for use with samples from dogs, prior to and after therapeutic intervention. Subsequently the assay will be used to predicting the bleeding phenotype and response to treatment in dogs with haemophilia A and B as a model for human haemophilia. The project is conducted in close collaboration with leading researchers from the University of North Carolina at Chapel Hill.
The starting date is February 1, 2014 or later, and the position is on a temporary contract. Part of the PostDoc project will take place at Translational Haemophilia Pharmacology in Måløv, Denmark and the other part in the lab of Dr. Tim Nichols in close collaboration with Dr. Alisa Wolberg at the University of North Carolina, Chapel Hill. Travel expenses between the US and Denmark will be reimbursed by Novo Nordisk.
The candidate will become part of two laboratories located in high impact centres of excellence within haemophilia and thus exposed to world class science and in addition serve as a liaison between the University of Chapel Hill and Novo Nordisk A/S.
Qualifications
You hold a PhD in medicine, veterinary medicine, pharmacology, biology or related disciplines. Solid knowledge on in vivo research in general and haemostasis research in particular is desirable. Experience with haemophilia research is considered an advantage. We require very good communication skills in English.
At Novo Nordisk your skills, dedication, and ambition help us change lives for the better. In exchange we offer you an opportunity to work with extraordinary talent and benefit from a range of possibilities for professional and personal development.
Contact
For further information, please call Bo Wiinberg on+45 3075 3030.
Deadline
18 December 2013
- Research & Development
- Denmark - Måløv
The position is offered as part of the Novo Nordisk R&D STAR Programme (Science, Talent, Attraction and Recruitment). This programme supports the brightest graduate students in biotechnology, life, medical and engineering sciences, who want to pursue a career in pharmaceutical R&D.
About the department
Translational Haemophilia Pharmacology is offering an international Postdoc fellowship to a highly motivated and ambitious candidate. Translational Haemophilia Pharmacology is a research unit focusing on research and development of drug candidates for the treatment of haemophilia; we support the Novo Nordisk haemophilia portfolio with knowledge generated in animal models of haemophilia.
The Job
The project will first focus on optimizing and validating a thrombin generation assay for use with samples from dogs, prior to and after therapeutic intervention. Subsequently the assay will be used to predicting the bleeding phenotype and response to treatment in dogs with haemophilia A and B as a model for human haemophilia. The project is conducted in close collaboration with leading researchers from the University of North Carolina at Chapel Hill.
The starting date is February 1, 2014 or later, and the position is on a temporary contract. Part of the PostDoc project will take place at Translational Haemophilia Pharmacology in Måløv, Denmark and the other part in the lab of Dr. Tim Nichols in close collaboration with Dr. Alisa Wolberg at the University of North Carolina, Chapel Hill. Travel expenses between the US and Denmark will be reimbursed by Novo Nordisk.
The candidate will become part of two laboratories located in high impact centres of excellence within haemophilia and thus exposed to world class science and in addition serve as a liaison between the University of Chapel Hill and Novo Nordisk A/S.
Qualifications
You hold a PhD in medicine, veterinary medicine, pharmacology, biology or related disciplines. Solid knowledge on in vivo research in general and haemostasis research in particular is desirable. Experience with haemophilia research is considered an advantage. We require very good communication skills in English.
At Novo Nordisk your skills, dedication, and ambition help us change lives for the better. In exchange we offer you an opportunity to work with extraordinary talent and benefit from a range of possibilities for professional and personal development.
Contact
For further information, please call Bo Wiinberg on+45 3075 3030.
Deadline
18 December 2013